This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carrier of infectious disease
Z21_CARRIER_INFECTIOUS_DISEA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
957 |
4. Check minimum number of eventsNone |
957 |
5. Include endpointsNone |
957 |
6. Filter based on genotype QC (FinnGen only) |
874 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z2
Similar endpoints
↥List of similar endpoints to
Carrier of infectious disease
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to communicable diseases
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 874 | 557 | 317 |
| Unadjusted period prevalence (%) | 0.18 | 0.20 | 0.15 |
| Median age at first event (years) | 50.43 | 43.10 | 63.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 957
- Matched controls
- 9570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
+∞
307.7
460
*
Z22.38
ICD-10 Finland
Carrier of other specified bacterium diseases
+∞
162.2
151
*
J04AB02
ATC
rifampicin; systemic
39.8
141.2
87
24
Z13.9
ICD-10 Finland
Special screening examination, unspecified
80.1
138.3
74
10
Z22.9
ICD-10 Finland
Carrier of infectious disease, unspecified
+∞
135.7
127
*
Z22.30
ICD-10 Finland
Latent tuberculosis
+∞
128.1
120
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
6.6
118.4
222
417
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
+∞
89.0
84
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
16.6
86.3
74
48
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
51.6
84.7
49
10
J01FF01
ATC
clindamycin; systemic
3.3
68.3
389
1638
Z22.8
ICD-10 Finland
Carrier of other infectious diseases
+∞
65.4
62
*
J01MA12
ATC
levofloxacin; systemic
3.4
57.2
258
928
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
53.3
169
478
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
10.9
47.6
52
50
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.5
39.8
155
500
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.3
38.5
67
113
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
4.8
37.4
90
204
A41.9
ICD-10 Finland
Sepsis, unspecified
6.2
37.4
66
113
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
33.2
273
1314
J01MA02
ATC
ciprofloxacin; systemic
2.3
32.9
402
2301
ZZA00
NOMESCO Finland
Split skin graft
6.3
31.9
55
92
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
31.1
192
801
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
30.4
173
691
ZXD05
NOMESCO Finland
Urgent procedure
2.3
30.4
361
2028
S97
ICPC
Chronic ulcer skin
4.0
29.7
90
243
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
29.0
377
2188
P19
ICPC
Drug abuse
11.0
28.8
31
29
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
27.7
177
748
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
27.7
287
1514
A46
ICD-10 Finland
Erysipelas
2.7
26.7
159
648
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
26.5
440
2778
ZXE00
NOMESCO Finland
One hour or less
2.1
26.4
422
2626
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.6
25.2
49
92
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
24.9
151
620
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
24.6
292
1616
R50.9
ICD-10 Finland
Fever, unspecified
2.5
24.4
181
819
L04AX03
ATC
methotrexate; systemic
2.9
24.4
126
475
N02AX02
ATC
tramadol; systemic, rectal
2.0
23.9
412
2610
H02AB06
ATC
prednisolone; systemic
2.0
23.8
474
3159
Z72.2
ICD-10 Finland
Drug use
22.0
23.6
34
16
J01DB01
ATC
cefalexin; oral
2.6
23.5
830
6829
SPAT1262
SPAT
Handing over of treatment supplies
2.4
23.4
185
861
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
22.9
165
735
N05CD07
ATC
temazepam; oral
2.8
22.3
123
480
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
22.2
226
1170
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
53.4
22.2
26
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
21.9
309
1811
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
21.9
92
308
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
21.8
133
546
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.9
21.8
34
51
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
21.6
75
222
N03AE01
ATC
clonazepam; systemic
3.5
21.3
75
224
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.1
21.1
59
150
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.6
20.8
50
113
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.4
20.8
41
78
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.4
20.6
52
122
N30.0
ICD-10 Finland
Acute cystitis
2.3
20.6
188
928
N05BA04
ATC
oxazepam; oral
2.0
20.5
278
1601
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.7
20.4
67
191
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
20.3
113
442
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
20.2
208
1078
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.1
20.1
43
88
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
20.1
136
587
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.0
19.7
91
321
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.7
19.7
37
67
N05BA01
ATC
diazepam; systemic, rectal
2.4
19.7
147
663
L04AA06
ATC
mycophenolic acid; systemic
6.1
19.6
34
57
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.1
19.4
55
141
C03CA01
ATC
furosemide; systemic
2.0
19.4
252
1423
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.4
19.4
49
115
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.0
19.3
93
336
J01CF05
ATC
flucloxacillin; systemic
3.1
19.2
86
298
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
19.1
46
104
L04AX01
ATC
azathioprine; systemic
3.7
19.0
63
181
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.9
18.9
34
59
A02BC02
ATC
pantoprazole; systemic
1.9
18.7
629
4822
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
18.6
114
468
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
18.6
112
456
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
18.6
106
420
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
5.6
18.5
35
64
J01EA01
ATC
trimethoprim; systemic
1.9
17.7
271
1615
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
14.9
17.7
29
20
NHQ40
NOMESCO Finland
Amputation of toe
6.9
17.5
27
40
WX730
NOMESCO Finland
Conventional respirator
7.9
17.5
24
31
S76
ICPC
Skin infection other
3.3
17.5
69
222
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.8
17.2
54
149
P01AB01
ATC
metronidazole; oral, rectal
1.8
17.1
401
2730
ZX120
NOMESCO Finland
Intravenous
2.6
17.0
106
439
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
16.9
80
286
Z2446
NOMESCO Finland
Social worker
2.8
16.9
88
332
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
16.8
74
254
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
64.5
16.8
19
*
SPAT1260
SPAT
Consultation of another employee
2.1
16.7
181
951
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
3.4
16.7
61
187
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.4
16.6
120
532
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.2
16.6
34
67
V03AE01
ATC
polystyrene sulfonate; oral
12.4
16.4
29
24
A06AD11
ATC
lactulose; oral
2.3
16.3
134
629
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
16.2
89
345
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.9
16.0
35
73
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
61.1
15.8
18
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
15.6
374
2544
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
15.5
204
1147
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
15.5
55
165
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.5
15.5
30
56
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
15.5
61
196
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.3
15.4
31
60
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
15.4
284
1786
SPAT1229
SPAT
Assessment of need for aid
2.9
15.4
75
273
SPAT1263
SPAT
Sampling
1.7
15.3
412
2892
N06AX11
ATC
mirtazapine; oral
1.8
15.2
326
2142
UJF32
NOMESCO Finland
Coloscopy
1.9
15.1
231
1366
SPAT1254
SPAT
Administration of medicine
2.2
15.0
148
748
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
15.0
61
200
N06AB06
ATC
sertraline; oral
2.2
14.8
139
688
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
14.7
95
399
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
14.7
129
621
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.3
14.7
114
521
E0000UV, ,
ATC
1.7
14.7
408
2881
N07BB01
ATC
disulfiram; oral
3.4
14.6
54
167
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.2
14.5
59
193
AA1AD
NOMESCO Finland
CT of head and brain
1.9
14.5
233
1398
Z41.8
ICD-10 Finland
Other procedures for purposes other than remedying health state
36.6
14.5
18
5
L04AB04
ATC
adalimumab; parenteral
4.3
14.4
37
88
A10AB05
ATC
insulin aspart; parenteral
2.6
14.4
88
360
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.2
14.4
58
189
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
14.4
76
289
SPAT1281
SPAT
Other administrative function
2.5
14.3
92
386
N02AA05
ATC
oxycodone; systemic
2.1
14.3
156
819
127
Kela drug reimbursment
Transplant complication
6.3
14.3
24
39
N05CF01
ATC
zopiclone; oral
1.8
14.2
288
1855
J01XC01
ATC
fusidic acid; systemic
5.8
14.2
26
46
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
12.2
14.1
25
21
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
14.1
195
1114
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
12.9
13.9
24
19
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
13.9
29
58
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
13.9
110
507
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
13.9
63
220
J01CA08
ATC
pivmecillinam; oral
1.7
13.9
406
2895
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
13.8
124
603
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.1
13.7
58
195
F10.24
ICD-10 Finland
Alcohol depence active use
5.3
13.5
27
52
N05AA02
ATC
levomepromazine; systemic
3.3
13.4
50
155
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
13.4
514
3923
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.0
13.4
29
60
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
13.4
43
121
UKC02
NOMESCO Finland
Cystoscopy
2.1
13.4
135
687
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.4
13.3
22
35
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
13.3
120
584
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.1
13.2
36
90
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.5
13.2
32
73
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
13.2
129
649
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
13.0
64
234
R11
ICD-10 Finland
Nausea and vomiting
2.3
12.9
102
470
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.6
12.8
75
300
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.7
12.8
41
115
P01BA02
ATC
hydroxychloroquine; oral
2.4
12.8
89
387
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
14.3
12.8
21
15
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
12.8
412
2996
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.3
12.7
103
479
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
12.7
347
2415
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
12.6
148
796
Z22.1
ICD-10 Finland
Carrier of other intestinal infectious diseases
+∞
12.5
12
*
WX002
NOMESCO Finland
Sedation and analgesia
1.9
12.5
177
1015
N02BE01
ATC
paracetamol; systemic, rectal
2.0
12.5
829
7292
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
24.7
12.5
17
7
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.7
12.5
23
41
TK800
NOMESCO Finland
Hemodialysis
4.6
12.4
29
64
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.3
12.3
47
148
Z25.1
ICD-10 Finland
Need for immunization against influenza
3.1
12.3
53
180
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.2
12.2
49
159
S18
ICPC
Laceration/cut
1.6
12.2
410
3000
A41.8
ICD-10 Finland
Other specified sepsis
4.8
12.2
27
57
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
12.1
64
243
N03AX16
ATC
[U] pregabalin
1.8
12.1
209
1275
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
12.1
91
410
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.0
12.1
34
87
N05AH04
ATC
quetiapine; oral
1.9
12.0
189
1120
B01AB05
ATC
enoxaparin; parenteral
1.7
12.0
269
1770
WW200
NOMESCO Finland
Immunization
3.9
12.0
35
92
H02AB04
ATC
methylprednisolone; systemic
2.0
11.9
139
745
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.8
403
2956
R4180
NOMESCO Finland
Podiatric therapy
5.6
11.7
22
40
J01MA06
ATC
norfloxacin; oral
2.1
11.7
121
621
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
11.6
113
567
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
11.5
201
1229
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.5
11.5
28
64
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
13.8
11.5
19
14
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.8
11.5
35
95
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
11.4
132
705
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
11.3
88
402
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
9.0
11.3
23
26
M79.6
ICD-10 Finland
Pain in limb
1.6
11.3
381
2778
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.4
11.3
28
65
SPAT1310
SPAT
Counselling related to known health issue
1.7
11.2
301
2074
M86.6
ICD-10 Finland
Other chronic osteomyelitis
20.3
11.2
16
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
11.0
89
414
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
10.9
107
537
Z11.2
ICD-10 Finland
Special screening examination for other bacterial diseases
15.7
10.8
17
11
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
10.8
74
319
WX212
NOMESCO Finland
Femoral plexus blockade
4.5
10.8
26
59
R53
ICD-10 Finland
Malaise and fatigue
1.7
10.7
239
1563
SPAT1312
SPAT
General health counselling
1.6
10.7
307
2145
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
10.7
84
386
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.8
10.6
54
201
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
10.6
61
242
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.6
10.5
62
249
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.8
10.5
52
191
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
10.5
202
1268
TQW80
NOMESCO Finland
Local dermatologic skincare
3.7
10.4
33
92
SPAT1255
SPAT
Intravenous administration of medicine
2.5
10.4
65
269
L28
ICPC
Limited function/disability (L)
1.9
10.4
145
825
A02BC01
ATC
omeprazole; systemic
1.7
10.3
246
1636
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
10.3
674
5692
N06AB04
ATC
citalopram; systemic
1.8
10.3
192
1194
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
10.3
128
701
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
2.4
10.2
75
334
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.0
10.2
29
75
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.7
10.2
32
89
L04AA01
ATC
[U] ciclosporin
8.0
10.1
22
28
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.0
10.1
22
28
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.1
10.1
21
42
L30.3
ICD-10 Finland
Infective dermatitis
3.1
10.1
42
140
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
10.0
297
2088
D07AB08
ATC
desonide; topical
2.0
9.9
111
585
L04AB01
ATC
etanercept; parenteral
4.5
9.8
24
55
SPAT1104
SPAT
Monitoring of emergency patient
2.5
9.8
63
264
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.0
9.8
21
43
XW000
NOMESCO Finland
Bone marrow biopsy
3.1
9.8
41
137
SPAT1211
SPAT
Application of soft bandage
2.2
9.8
89
434
SPAT1301
SPAT
No procedures
1.6
9.8
280
1948
R33
ICD-10 Finland
Retention of urine
2.4
9.8
68
296
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
9.7
187
1171
Z71.8
ICD-10 Finland
Other specified counselling
1.6
9.7
303
2150
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.7
192
1212
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
9.7
68
297
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
9.7
245
1652
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
9.7
193
1222
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
11.5
9.6
17
15
A11CC03
ATC
alfacalcidol; systemic
3.9
9.6
28
74
N06AB03
ATC
fluoxetine; oral
1.9
9.5
123
681
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
15.2
9.5
15
10
WZC30
NOMESCO Finland
Teaching
1.9
9.5
137
788
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.2
9.4
19
37
N03AX12
ATC
[U] gabapentin; oral
1.8
9.3
144
845
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
9.3
105
556
T74.1
ICD-10 Finland
Physical abuse
3.5
9.3
31
90
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.3
9.2
34
105
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.2
378
2848
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
9.2
68
304
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
13.8
9.2
15
11
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
9.2
92
466
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
9.1
92
467
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.3
9.1
33
101
Z94.0
ICD-10 Finland
Kidney transplant status
8.4
9.1
19
23
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
9.1
78
372
J01XX08
ATC
linezolid; systemic
10.2
9.0
17
17
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.5
9.0
55
225
X58
ICD-10 Finland
Exposure to other specified factors
1.8
9.0
142
838
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
8.9
78
374
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
8.9
63
276
M05BA04
ATC
alendronic acid; oral
2.3
8.9
67
302
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.9
369
2782
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
8.9
64
283
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
12.7
8.9
15
12
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
8.9
76
362
NGQ20
NOMESCO Finland
Amputation of lower leg
9.6
8.8
17
18
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
8.8
107
581
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
8.8
49
192
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
8.8
229
1552
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.9
8.7
25
65
WX402
NOMESCO Finland
General anaesthesia
1.7
8.7
185
1189
NF3AA
NOMESCO Finland
Femur X-ray examination
4.0
8.6
24
61
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
8.6
59
255
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
8.6
70
326
Z3231
NOMESCO Finland
Registered nurse
1.6
8.6
241
1660
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
8.6
84
421
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
8.6
39
137
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.1
8.6
17
19
I50.0
ICD-10 Finland
Congestive heart failure
2.4
8.5
60
263
N05BE01
ATC
buspirone; oral
3.0
8.5
37
127
W84
ICPC
Pregnancy high risk
2.5
8.5
54
226
L88
ICPC
Rheumatoid/seropositive arthritis
2.8
8.4
42
155
L04AA13
ATC
[U] leflunomide
3.5
8.4
28
81
A07AA09
ATC
vancomycin; oral
4.7
8.4
19
41
SPAT1283
SPAT
Restricted health certificate
1.7
8.4
196
1291
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
8.4
48
191
J01MA14
ATC
moxifloxacin; systemic
2.1
8.4
82
412
Z44.1
ICD-10 Finland
Fitting and adjustment of artificial leg (complete)(partial)
+∞
8.3
8
*
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.6
8.3
17
20
J01MA01
ATC
ofloxacin; systemic
2.2
8.3
73
351
L01BA01
ATC
methotrexate; systemic
2.9
8.3
38
134
N06AA09
ATC
amitriptyline; systemic
2.1
8.3
82
413
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.3
275
1968
WX320
NOMESCO Finland
Spinalanesthesy
1.6
8.3
211
1419
H02AB07
ATC
prednisone; oral
1.8
8.3
122
705
N06AX16
ATC
venlafaxine; oral
1.8
8.2
139
837
L40.5
ICD-10 Finland
Arthropathic psoriasis
4.3
8.2
21
50
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.6
8.2
20
31
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
8.2
184
1198
L04AD02
ATC
tacrolimus; systemic
7.6
8.2
18
24
JN4BD
NOMESCO Finland
Extensive body CT
2.0
8.1
86
444
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
4.8
8.1
18
38
Z00.0
ICD-10 Finland
General medical examination
1.7
8.1
176
1136
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.0
8.1
36
125
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
17.3
8.1
12
7
A10AE04
ATC
insulin glargine; parenteral
2.0
8.1
89
467
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.0
155
969
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.9
8.0
37
131
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
22.2
8.0
11
5
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.3
8.0
20
47
J05AB01
ATC
aciclovir; systemic
1.6
8.0
201
1348
D07AD01
ATC
clobetasol; topical
1.8
7.9
138
838
UDC00
NOMESCO Finland
Ear microscopy
2.1
7.9
73
358
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.0
7.9
22
56
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
7.8
47
191
A10BB12
ATC
glimepiride; oral
2.3
7.8
56
247
J01CE08
ATC
benzathine benzylpenicillin; parenteral
8.5
7.8
16
19
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
7.8
112
641
J02AC01
ATC
fluconazole; systemic
1.5
7.8
353
2693
QDA10
NOMESCO Finland
Incision of skin of lower limb
9.5
7.8
15
16
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
9.5
7.8
15
16
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.7
7.8
42
162
N03AG01
ATC
valproic acid; systemic, rectal
2.2
7.8
64
300
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.0
7.8
34
117
N05AH03
ATC
olanzapine; systemic
2.2
7.8
68
327
R4110
NOMESCO Finland
Physiotherapy
1.6
7.8
231
1610
A10AC01
ATC
insulin (human); parenteral
2.1
7.7
77
389
B03XA02
ATC
darbepoetin alfa; parenteral
3.9
7.7
22
57
R60.0
ICD-10 Finland
Localized oedema
1.9
7.7
100
554
J01DA01
ATC
[U] cefalexin
1.5
7.7
551
4596
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.8
7.7
23
62
D07AC01
ATC
betamethasone; topical
1.5
7.7
307
2283
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.4
7.6
52
225
Z20.1
ICD-10 Finland
Contact with and exposure to tuberculosis
12.0
7.6
13
11
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.0
7.6
13
11
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
25.2
7.6
10
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.6
127
763
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
3.9
7.6
22
58
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
7.5
228
1594
D07AC13
ATC
mometasone; topical
1.5
7.5
251
1793
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.6
7.5
41
159
S10
ICPC
Boil/carbuncle
2.2
7.5
63
298
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.5
227
1588
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.5
7.4
18
41
XLA10, ,
NOMESCO Finland
2.6
7.4
41
160
N05AF03
ATC
chlorprothixene; systemic
3.1
7.4
30
99
M54.5
ICD-10 Finland
Low back pain
1.5
7.3
321
2426
R10.0
ICD-10 Finland
Acute abdomen
2.7
7.3
37
138
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
11.0
7.3
13
12
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
11.0
7.3
13
12
Z29.0
ICD-10 Finland
Isolation
+∞
7.3
7
*
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
7.3
7
*
R06AE07
ATC
cetirizine; oral
1.5
7.3
403
3188
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.8
7.3
36
133
V03AE02
ATC
sevelamer; oral
15.9
7.2
11
7
A28
ICPC
Limited function/disability NOS
1.8
7.2
120
719
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
4.5
7.2
17
38
N05BA02
ATC
chlordiazepoxide; systemic
3.3
7.1
26
80
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
7.1
92
509
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
7.1
57
264
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
20.2
7.1
10
5
E000001, ,
ATC
1.6
7.1
187
1263
C07AB07
ATC
bisoprolol; oral
1.5
7.1
360
2796
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
7.1
484
3975
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
7.0
86
468
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.0
486
3999
S06.0
ICD-10 Finland
Concussion
1.8
7.0
104
602
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
7.0
66
327
N05AX08
ATC
risperidone; systemic
2.0
7.0
77
404
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
7.0
101
580
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
6.9
66
328
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
5.5
6.9
19
35
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.6
6.9
15
20
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
13.9
6.9
11
8
A05AA02
ATC
ursodeoxycholic acid; oral
3.5
6.9
23
67
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.9
203
1409
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
6.8
60
289
WX213
NOMESCO Finland
Lower leg blockade
8.3
6.8
14
17
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.8
6.8
34
126
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
6.8
79
422
N06AB10
ATC
escitalopram; oral
1.6
6.8
204
1420
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.1
6.8
60
290
B17.1
ICD-10 Finland
Acute hepatitis C
16.8
6.8
10
6
N76.0
ICD-10 Finland
Acute vaginitis
2.0
6.8
77
409
R03BB04
ATC
tiotropium bromide; inhalant
1.9
6.7
82
446
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.7
154
1006
R05
ICD-10 Finland
Cough
1.6
6.7
182
1239
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
6.7
37
145
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.7
273
2029
M54
ICD-10 Finland
Dorsalgia
1.7
6.7
115
696
J32.4
ICD-10 Finland
Chronic pansinusitis
3.8
6.7
20
54
N02BF02
ATC
pregabalin; oral
2.2
6.7
54
252
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.5
6.7
16
25
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
6.6
29
100
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
5.5
6.6
18
33
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.5
6.6
41
170
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.4
6.6
23
69
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.4
6.6
23
69
U71
ICPC
Cystitis/urinary infection other
2.1
6.6
64
321
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.2
6.6
17
41
D05AX52
ATC
calcipotriol, combinations; topical
2.3
6.6
47
208
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.6
246
1795
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.9
6.6
19
50
ZXA05
NOMESCO Finland
Left side
1.6
6.5
187
1287
L17
ICPC
Foot/toe symptom/complaint
1.5
6.5
239
1735
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
6.5
115
700
N18.0
ICD-10 Finland
End-stage renal disease
6.9
6.5
15
22
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
6.5
69
357
L04AD01
ATC
ciclosporin; systemic
3.7
6.5
20
55
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
6.5
18
34
J03.0
ICD-10 Finland
Streptococcal tonsillitis
2.4
6.5
43
184
XKC03
NOMESCO Finland
Water cystometry
2.9
6.4
29
102
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
6.4
95
550
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.7
6.4
32
119
H53.2
ICD-10 Finland
Diplopia
2.7
6.4
32
119
I95.9
ICD-10 Finland
Hypotension, unspecified
3.8
6.4
19
51
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
6.4
126
792
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.6
6.3
35
137
ZXA10
NOMESCO Finland
Bilateral
1.6
6.3
150
987
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.9
6.3
29
103
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
6.3
32
120
Z22.4
ICD-10 Finland
Carrier of infections with a predominantly sexual mode of transmission
+∞
6.3
6
*
B95.6
ICD-10 Finland
Staphylococcus aureus as the cause of diseases classified to other chapters
+∞
6.3
6
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.7
6.2
19
52
G04BD11
ATC
fesoterodine; oral
3.2
6.2
24
77
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.0
6.2
17
43
UJF92
NOMESCO Finland
Capsular endoscopy
3.2
6.2
23
72
A02BC05
ATC
esomeprazole; systemic
1.4
6.1
327
2548
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
6.1
50
234
JN4AD
NOMESCO Finland
Body CT examination
1.9
6.1
74
401
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.7
6.1
13
17
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.1
85
482
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.1
6.1
25
83
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.2
6.1
16
39
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
4.2
6.1
16
39
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
12.6
6.1
10
8
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
12.6
6.1
10
8
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
6.1
68
359
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.8
6.1
30
111
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.0
104
629
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.7
6.0
31
117
D05AX02
ATC
calcipotriol; topical
2.7
6.0
31
117
WW500
NOMESCO Finland
Blood transfusion
2.4
6.0
39
165
SPAT1167
SPAT
Insertion of urinary catheter
3.0
6.0
26
89
J01CF02
ATC
cloxacillin; systemic
3.5
6.0
20
58
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.3
6.0
22
68
Z01.2
ICD-10 Finland
Dental examination
1.4
6.0
405
3286
E66.00
ICD-10 Finland
Metabolic syndrome
2.2
6.0
48
223
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
347
685
7.38
181.78
5.0
3.0
—
—
—
0
0
130
260
5.63
63.21
2.1
1.5
132.92
0.33
iu/ml
0.78
41
42
180
591
3.52
45.27
3.1
2.4
10.83
10.33
g/l
0.78
160
538
583
3593
2.59
44.17
11.2
5.6
2.79
2.78
%
0.03
567
3367
89
177
5.44
43.16
2.6
1.6
—
—
—
0
0
41
34
12.55
41.26
1.9
1.6
734200.00
1020591.67
iu/ml
—
9
6
589
3735
2.50
40.61
8.3
5.9
9.73
11.09
umol/l
4.03
564
3528
589
3739
2.50
40.45
11.2
5.7
28.01
28.24
%
0.18
574
3527
57
78
7.71
39.79
7.9
5.9
12.47
10.64
mg/l
1.48
52
71
454
2614
2.40
38.06
4.7
3.4
127.04
84.57
e6/l
0.59
351
1772
577
3696
2.41
37.81
10.4
5.5
56.66
57.21
%
0.50
561
3482
35
26
13.93
37.53
3.8
2.2
—
—
—
0
0
73
141
5.52
36.47
4.9
3.4
4.48
4.37
e9/l
0.14
73
141
74
146
5.41
36.12
5.3
3.7
59.28
58.03
%
0.30
74
146
645
4405
2.42
35.58
14.1
8.6
4.31
4.08
e9/l
1.49
591
3856
68
127
5.69
35.21
3.9
2.3
15.24
16.18
%
0.77
31
64
154
534
3.25
35.00
5.3
3.4
1.21
1.23
mmol/l
2.18
143
462
495
3043
2.30
34.62
15.1
12.5
1.17
1.21
inr
0.53
215
925
756
5626
2.64
33.32
12.7
7.1
77.97
76.53
u/l
0.38
715
5274
385
2157
2.31
33.26
4.1
3.0
78.39
96.49
e6/l
0.15
326
1645
474
2929
2.23
31.91
7.4
4.7
34.28
36.02
g/l
6.71
439
2728
138
477
3.21
31.38
2.0
1.6
—
—
—
0
0
135
464
3.22
30.97
2.0
1.6
1.30
1.53
g/l
0.59
125
425
292
1493
2.38
30.77
3.6
2.4
13.16
6.47
e6/l
0.58
270
1338
389
2248
2.23
30.59
3.2
2.5
52.18
59.51
u/l
1.99
350
2094
486
3086
2.17
29.94
8.3
5.6
1.21
1.21
mmol/l
0.04
457
2809
79
194
4.35
29.63
4.1
2.9
—
—
—
0
0
521
3409
2.16
29.58
10.1
6.3
1.21
1.21
mmol/l
0.13
403
2911
193
827
2.67
29.55
10.2
5.7
1.06
1.04
mmol/l
0.45
185
770
418
2558
2.13
27.73
4.5
3.0
—
—
—
0
0
36
48
7.75
25.61
2.0
2.3
—
—
—
0
0
407
2552
2.04
24.47
4.3
3.2
32.56
30.50
u/l
0.82
385
2426
153
644
2.64
23.97
2.5
2.3
0.20
0.22
g/l
1.35
142
613
335
1991
2.05
23.06
3.9
2.9
0.42
0.41
e6/l
0.01
285
1497
588
4260
1.99
22.74
7.5
4.6
6.77
6.57
mmol/l
0.92
547
3900
203
996
2.32
22.72
3.5
2.3
2.25
2.38
g/l
2.14
185
926
36
55
6.76
22.69
1.8
1.4
—
—
—
0
0
453
3009
1.96
22.56
2.9
2.2
73.61
74.80
nmol/l
0.40
423
2724
320
1889
2.04
22.30
2.8
2.0
3.28
2.94
mg/l
1.13
289
1634
188
923
2.29
20.87
3.5
2.4
22.04
23.06
%
0.39
167
791
703
5535
2.02
20.03
7.4
3.9
14.83
11.03
mm/h
7.03
663
5115
210
1096
2.17
20.00
3.5
2.3
12.08
13.53
umol/l
1.96
196
1025
392
2577
1.88
19.29
5.4
3.4
38.67
38.31
ng/l
0.02
267
1617
155
727
2.35
19.02
3.1
2.5
1.86
1.79
%
0.32
138
652
326
2033
1.92
18.76
5.8
3.7
0.01
0.01
estimate
0.17
181
696
154
730
2.32
18.41
4.1
4.1
221.91
251.13
u/l
1.49
146
688
201
1063
2.13
18.36
4.1
3.4
0.81
0.82
mmol/l
0.54
191
1002
659
5177
1.88
17.59
6.7
4.2
4787.92
2108.22
e6/l
0.26
13
64
75
258
3.07
16.97
2.2
1.6
0.25
0.23
g/l
0.61
70
244
148
719
2.25
16.61
2.4
2.0
354.79
379.86
nmol/l
0.76
137
660
25
36
7.10
16.60
2.4
2.4
874.72
726.42
u/ml
0.22
25
36
102
424
2.57
16.18
6.0
3.4
1.74
1.77
mmol/l
0.03
76
306
275
1691
1.88
16.10
1.7
1.4
2.48
2.30
g/l
0.88
197
1049
75
272
2.91
15.46
2.3
1.6
1.19
1.17
g/l
0.16
70
256
57
177
3.36
15.26
1.5
3.7
58.80
91.76
mg/l
0.42
40
141
57
177
3.36
15.26
1.5
3.7
49.78
30.72
mg/l
2.01
41
141
512
3824
1.73
15.19
6.8
4.7
0.00
0.00
estimate
0.50
185
705
513
3837
1.73
15.11
5.3
3.4
0.00
0.00
estimate
0.80
192
744
104
451
2.47
15.07
6.0
3.3
5.13
5.12
kpa
0.04
99
434
95
396
2.55
14.96
2.1
1.4
—
—
—
0
0
197
1108
1.98
14.94
2.4
1.8
—
—
—
0
0
514
3874
1.71
14.48
5.3
3.4
0.00
0.00
estimate
0.50
181
683
111
505
2.36
14.46
2.2
2.6
65.76
66.80
g/l
0.65
104
462
70
258
2.85
14.01
2.4
2.0
—
—
—
0
0
497
3744
1.68
13.76
4.1
2.8
128.81
100.40
ug/l
1.73
462
3497
47
139
3.50
13.58
1.7
1.4
—
—
—
0
0
56
185
3.15
13.58
1.8
1.5
—
—
—
0
0
17
6
28.80
12.99
3.0
2.0
—
—
—
0
0
341
2363
1.69
12.69
4.2
3.3
2.33
2.35
mmol/l
1.64
307
2101
392
2826
1.66
12.48
2.0
1.9
94.95
96.16
pmol/l
0.21
223
1497
276
1813
1.73
12.46
3.5
2.6
346.99
5921.42
umol/l
6.09
245
1602
30
69
4.46
12.22
5.5
3.3
—
—
—
0
0
33
82
4.13
12.19
1.8
1.5
—
—
—
0
0
17
8
21.60
12.03
3.0
1.9
—
—
—
0
0
26
54
4.92
11.95
2.0
1.4
—
—
—
0
0
176
1026
1.88
11.78
2.6
1.7
1.44
1.42
%
0.15
152
926
26
55
4.83
11.71
1.9
2.2
0.24
0.18
e9/l
0.56
20
48
27
59
4.68
11.70
1.9
2.1
2201.45
476.06
e6/l
0.56
20
49
22
40
5.61
11.68
2.1
1.5
—
—
—
0
0
869
7829
2.20
11.47
29.1
12.4
22.22
22.43
mg/l
0.07
771
6087
41
125
3.38
11.33
1.9
1.6
—
—
—
0
0
36
101
3.66
11.27
1.9
1.5
—
—
—
0
0
46
152
3.13
11.17
3.6
2.3
121.70
131.52
g/l
2.09
40
117
51
179
2.95
11.17
1.8
1.5
—
—
—
0
0
76
328
2.43
11.11
1.4
1.4
—
—
—
0
0
401
2970
1.60
11.08
5.8
3.5
—
—
—
0
0
641
5306
1.63
11.07
4.7
3.0
46.80
42.01
u/l
0.54
598
5018
263
1757
1.69
10.95
3.6
3.0
2870.36
1300.32
ng/l
1.86
215
1458
480
3719
1.58
10.89
3.4
2.6
—
—
—
0
0
271
1837
1.66
10.63
5.1
3.7
91.08
92.44
%
0.39
259
1781
193
1194
1.77
10.55
2.2
1.6
1362.09
1183.41
nmol/l
1.41
141
909
21
23
9.31
10.54
3.5
5.7
—
—
—
0
0
812
7195
1.85
10.51
24.2
11.1
87.75
86.63
ml/min/173m2
0.60
720
5811
50
180
2.88
10.48
1.4
1.3
—
—
—
0
0
46
160
2.97
10.25
6.0
6.0
1648.50
318.52
iu/ml
—
8
23
16
11
14.77
10.02
1.3
1.2
—
—
—
0
0
29
76
3.90
10.00
2.2
1.7
70.76
60.83
%
0.67
21
54
18
18
10.17
9.54
2.7
2.3
—
—
—
0
0
32
93
3.53
9.53
1.8
1.4
—
—
—
0
0
49
185
2.74
9.42
1.2
1.2
—
—
—
0
0
218
1436
1.67
9.40
2.1
1.6
483.19
36587788.13
pmol/l
2.02
171
1219
34
105
3.32
9.24
1.9
1.5
—
—
—
0
0
38
128
3.05
8.97
1.9
1.4
—
—
—
0
0
61
265
2.39
8.81
2.8
2.3
1.43
1.40
g/l
0.10
56
232
25
65
3.92
8.73
4.7
3.3
62.12
56.81
%
0.53
25
58
34
110
3.17
8.59
1.9
1.4
—
—
—
0
0
700
6078
1.56
8.44
4.9
4.0
14.74
14.62
pmol/l
0.60
645
5566
46
181
2.62
8.19
1.3
1.2
283.89
237.43
u/ml
0.53
28
110
850
7774
1.84
8.10
27.4
13.8
139.09
139.59
mmol/l
6.86
827
7554
851
7797
1.83
7.91
27.9
13.8
3.94
3.95
mmol/l
0.15
829
7558
36
128
2.88
7.76
1.1
1.1
—
—
—
0
0
775
6937
1.62
7.73
29.8
14.8
14.78
14.61
%
0.42
769
6814
59
268
2.28
7.73
2.0
1.9
—
—
—
0
0
294
2168
1.51
7.62
8.5
3.2
7.13
7.78
mmol/l
1.65
248
1844
107
612
1.84
7.49
5.6
3.6
1.61
1.87
mmol/l
0.34
89
507
90
487
1.94
7.46
5.9
3.9
94.86
79.37
ng/l
1.00
77
435
40
154
2.67
7.45
1.6
1.4
108.32
105.96
u/ml
—
9
28
107
614
1.84
7.41
5.6
3.6
5.90
5.84
kpa
0.22
102
599
247
1765
1.54
7.38
1.9
1.7
1.64
1.07
mg/l
0.57
182
1343
170
1116
1.64
7.28
3.4
2.7
4.09
2.61
e6/l
0.84
109
599
51
224
2.35
7.23
1.2
2.2
2.68
2.97
g/l
1.46
46
207
197
1344
1.59
7.20
1.4
1.3
76.18
29.30
iu/ml
1.64
72
433
53
238
2.30
7.14
1.2
2.1
3.57
3.66
g/l
0.26
48
221
53
238
2.30
7.14
1.2
2.1
7.25
7.33
g/l
0.15
48
221
53
238
2.30
7.14
1.2
2.1
—
—
—
0
0
27
86
3.20
7.03
2.1
1.5
30.81
32.24
pg
0.63
27
86
43
177
2.50
7.01
2.0
1.4
—
—
—
0
0
33
120
2.81
6.86
1.7
1.5
—
—
—
0
0
18
44
4.15
6.83
2.4
2.9
36642.83
42216.02
ug/l
0.61
18
44
158
1038
1.63
6.73
3.9
2.4
195.60
117.28
ug/g
1.89
123
816
136
860
1.68
6.72
4.0
2.7
6.74
8.12
umol/l
0.42
110
728
116
703
1.74
6.69
3.1
2.3
27.24
103.04
u/l
0.56
103
582
18
33
5.54
6.63
2.2
1.5
—
—
—
0
0
18
33
5.54
6.63
2.2
1.5
—
—
—
0
0
225
1609
1.52
6.62
1.6
1.5
20.34
20.86
nmol/l
0.20
199
1390
275
2062
1.47
6.38
3.0
2.1
189.51
207.11
u/l
0.13
254
1939
28
97
2.94
6.36
1.3
1.2
—
—
—
0
0
52
244
2.20
6.34
2.0
1.8
—
—
—
0
0
37
149
2.54
6.34
1.7
1.7
—
—
—
0
0
261
1945
1.47
6.23
1.3
1.3
1.68
1.69
u/ml
0.00
86
513
156
1044
1.59
6.13
2.8
2.2
31.14
29.73
s
1.89
150
1012
25
83
3.07
6.11
1.2
1.2
—
—
—
0
0
214
1538
1.50
6.10
2.6
2.2
—
—
—
0
0
48
222
2.22
6.07
1.3
2.2
11.16
10.46
g/l
0.36
43
204
122
771
1.67
6.03
2.2
1.8
—
—
—
0
0
91
532
1.79
5.94
2.3
2.3
30.79
20.03
au/ml
—
7
44
17
34
5.07
5.89
10.8
5.3
97.89
53.00
u/ml
—
9
6
41
180
2.33
5.86
1.4
1.5
489.75
421.11
mg/l
0.67
36
171
15
26
5.84
5.85
1.9
1.4
1.60
7.86
%
—
5
7
37
156
2.43
5.78
3.1
1.8
12196.67
14975.23
e6/l
0.22
21
119
122
780
1.65
5.77
2.3
1.8
—
—
—
0
0
87
509
1.78
5.67
1.5
1.5
—
—
—
0
0
61
318
1.98
5.67
1.5
2.1
41.15
38.67
u/l
0.40
53
288
17
47
3.66
5.50
1.9
2.9
38.71
41.95
%
—
7
28
8
5
16.12
5.41
1.0
1.4
—
—
—
0
0
176
1243
1.51
5.41
3.0
2.9
2.46
2.44
mmol/l
1.30
150
1088
24
84
2.90
5.38
1.6
1.7
—
—
—
0
0
785
7207
1.50
5.36
5.9
4.7
1.83
2.01
mu/l
0.50
728
6663
642
5689
1.39
5.31
3.8
3.4
—
—
—
0
0
875
8246
1.71
5.20
17.7
9.3
27.05
25.75
u/l
1.16
847
7959
37
164
2.31
5.20
1.5
1.7
18.81
11.20
e6/l
0.37
26
132
21
70
3.04
5.12
3.3
2.1
—
—
—
0
0
83
495
1.74
5.08
3.4
3.4
4.38
4.60
pmol/l
0.97
75
437
9
9
10.08
5.03
1.2
2.9
—
—
—
0
0
15
41
3.70
4.94
1.4
1.1
—
—
—
0
0
12
20
6.06
4.92
1.2
1.3
—
—
—
0
0
190
1393
1.45
4.82
2.4
2.0
—
—
—
0
0
43
211
2.09
4.74
1.3
2.3
0.22
1.26
g/l
2.23
36
191
79
478
1.71
4.61
1.4
1.4
—
—
—
0
0
79
478
1.71
4.61
1.4
1.4
—
—
—
0
0
45
228
2.02
4.57
1.3
1.2
—
—
—
0
0
79
480
1.70
4.55
1.4
1.4
—
—
—
0
0
45
229
2.01
4.52
1.3
1.2
—
—
—
0
0
79
481
1.70
4.51
1.4
1.4
—
—
—
0
0
22
82
2.72
4.44
1.0
1.1
—
—
—
0
0
13
28
4.69
4.38
1.0
1.2
—
—
—
0
0
15
45
3.37
4.33
1.5
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
178
2.12
4.32
3.7
3.8
0.33
0.34
u/ml
0.06
25
101
30
133
2.30
4.26
1.5
1.6
—
—
—
0
0
30
133
2.30
4.26
1.5
1.6
—
—
—
0
0
17
56
3.07
4.25
1.2
1.2
—
—
—
0
0
9
13
6.98
4.17
1.8
1.4
—
—
—
0
0
53
294
1.85
4.16
1.5
1.3
7.60
8.89
u/l
0.43
48
235
14
35
4.04
4.11
1.1
1.3
—
—
—
0
0
42
218
1.97
4.02
1.4
1.2
6.17
2.83
u/ml
—
6
28
39
198
2.01
3.97
1.2
2.1
37.31
38.27
g/l
0.36
34
181
42
221
1.94
3.88
1.5
1.4
—
—
—
0
0
42
221
1.94
3.88
1.4
1.2
20.13
9.52
u/ml
—
6
40
10
19
5.31
3.83
1.3
1.1
100.20
97.84
%
—
10
19
41
217
1.93
3.73
2.0
2.2
304.33
244.29
ug/l
0.25
35
204
25
109
2.33
3.71
1.3
1.1
—
—
—
0
0
62
377
1.69
3.60
2.0
1.7
—
—
—
0
0
82
539
1.57
3.50
2.4
2.3
4699.88
5715.24
u/l
0.13
33
229
17
63
2.73
3.50
1.7
1.4
22910.10
275014.40
e6/l
—
10
45
18
69
2.64
3.48
1.7
1.6
—
—
—
0
0
18
69
2.64
3.48
1.7
1.6
—
—
—
0
0
18
69
2.64
3.48
1.7
1.6
—
—
—
0
0
11
27
4.11
3.40
2.3
1.5
25.91
28.81
umol/l
0.40
11
27
11
27
4.11
3.40
1.5
2.7
—
—
—
0
0
11
27
4.11
3.40
2.5
2.2
—
—
—
0
0
66
415
1.63
3.39
1.9
1.6
—
—
—
0
0
168
1282
1.38
3.35
1.4
1.3
24.59
11.79
u/ml
1.14
81
501
14
48
2.95
3.31
1.2
1.2
—
16.38
—
0
8
44
250
1.80
3.25
3.1
3.5
55.42
1552.26
u/ml
1.33
36
221
12
34
3.56
3.20
1.4
1.7
1.42
1.12
nmol/l
—
7
25
38
208
1.86
3.17
1.5
1.5
243.95
290.98
ug/g
0.65
21
110
158
1206
1.37
3.14
3.0
2.5
1.20
1.00
e6/l
0.32
96
684
17
67
2.57
3.14
1.1
1.1
—
—
—
0
0
17
67
2.57
3.14
1.1
1.1
—
—
—
0
0
15
56
2.71
3.07
1.3
1.6
—
—
—
0
0
16
62
2.61
3.05
1.8
1.5
—
—
—
0
0
17
68
2.53
3.05
1.1
1.1
—
—
—
0
0
17
68
2.53
3.05
1.1
1.1
—
—
—
0
0
17
68
2.53
3.05
1.1
1.1
—
—
—
0
0
86
591
1.50
3.03
9.9
6.5
1.42
1.37
mmol/l
0.10
81
574
12
37
3.27
2.94
1.4
1.3
163.92
175.45
mmol/24h
0.15
12
37
82
562
1.50
2.93
1.5
1.4
—
—
—
0
0
29
149
1.98
2.92
1.8
1.3
—
—
—
0
0
29
149
1.98
2.92
1.8
1.3
—
—
—
0
0
241
1977
1.29
2.91
5.8
3.9
26.98
10.62
mg/mmol
1.68
161
1256
6
9
6.70
2.87
1.2
1.6
—
—
—
0
0
23
109
2.14
2.86
1.9
1.4
—
—
—
0
0
32
172
1.89
2.84
1.5
1.4
—
—
—
0
0
775
7315
1.31
2.77
4.8
4.0
5.87
5.81
mmol/l
0.59
708
6716
5
6
8.37
2.75
3.4
1.8
2.24
3.00
mg/l
—
5
6
227
1862
1.29
2.73
3.2
2.1
—
—
—
0
0
12
40
3.03
2.70
1.3
1.6
—
—
—
0
0
12
40
3.03
2.70
1.3
1.6
—
—
—
0
0
9
24
3.78
2.67
1.0
1.0
—
—
—
0
0
89
633
1.45
2.66
4.4
4.4
4.12
31.64
ug/l
1.38
70
517
11
36
3.08
2.57
1.3
1.1
964.27
1364.72
miu/ml
0.86
11
36
6
11
5.48
2.54
1.0
1.1
—
—
—
0
0
6
11
5.48
2.54
1.0
1.1
—
—
—
0
0
17
75
2.29
2.52
1.8
1.8
—
—
—
0
0
54
350
1.58
2.51
1.2
1.3
195.66
234.21
miu/ml
0.34
23
176
226
1871
1.27
2.51
1.8
1.6
1.40
1.38
mmol/l
0.14
186
1604
98
718
1.41
2.51
8.9
7.9
1.07
1.10
mmol/l
0.03
83
568
11
37
3.00
2.49
1.4
1.3
—
—
—
0
0
33
188
1.78
2.48
2.1
2.0
4.15
4.38
umol/l
0.16
25
141
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
720
6766
1.26
2.45
6.5
5.1
39.65
38.97
mmol/mol
1.04
661
6320
10
32
3.15
2.44
1.3
1.3
—
—
—
0
0
10
32
3.15
2.44
1.2
1.0
180.93
194.71
iu/ml
—
10
32
16
70
2.31
2.42
1.6
1.3
4.33
0.73
u/ml
—
10
38
11
38
2.92
2.42
2.8
1.7
—
—
—
0
0
6
12
5.02
2.40
1.3
1.3
—
—
—
0
0
6
12
5.02
2.40
1.3
1.6
—
—
—
0
0
54
800
0.66
2.39
1.5
1.6
—
—
—
0
0
17
77
2.23
2.38
1.2
1.1
—
—
—
0
0
45
285
1.61
2.32
1.8
1.8
—
—
—
0
0
90
660
1.40
2.30
1.3
1.2
56.00
139.86
iu/ml
4.18
32
261
65
451
1.47
2.24
1.4
1.4
19.63
23.43
iu/l
0.53
58
375
16
73
2.21
2.22
1.5
1.2
—
—
—
0
0
5
9
5.58
2.21
1.4
1.0
—
—
—
0
0
12
48
2.52
2.19
1.2
1.0
—
—
—
0
0
8
24
3.35
2.18
2.0
2.0
74.25
57.26
ug/l
—
8
24
16
74
2.18
2.15
1.5
1.3
—
—
—
0
0
9
30
3.02
2.15
1.3
1.8
—
—
—
0
0
9
30
3.02
2.15
1.3
1.8
—
—
—
0
0
26
145
1.82
2.12
1.4
1.4
17.93
19.14
u/l
0.07
21
123
116
1473
0.76
2.09
3.6
4.2
22.17
21.36
%
0.22
47
674
23
124
1.88
2.08
1.0
1.1
—
—
—
0
0
9
31
2.92
2.07
1.4
1.7
—
—
—
0
0
5
10
5.02
2.07
3.8
10.9
0.29
0.38
umol/l
—
5
10
5
10
5.02
2.07
1.2
1.4
—
—
—
0
0
6
15
4.02
2.04
1.3
1.3
—
—
—
0
0
16
76
2.12
2.03
4.6
1.7
—
—
—
0
0
95
721
1.35
2.00
9.0
7.8
5.33
5.08
kpa
1.59
90
683
95
721
1.35
2.00
9.0
7.8
11.28
12.39
kpa
1.77
90
687
190
1584
1.25
1.98
1.7
1.5
—
—
—
0
0
222
1884
1.23
1.96
4.6
3.3
854.03
290.97
mg/l
0.77
143
1236
26
149
1.77
1.96
1.3
1.2
3.69
7.54
u/ml
0.85
13
69
8
27
2.98
1.94
1.3
1.0
—
—
—
0
0
109
849
1.32
1.93
1.5
1.5
—
—
—
0
0
6
16
3.77
1.93
1.5
1.3
—
—
—
0
0
16
78
2.07
1.91
1.3
1.4
44.27
35.61
nmol/l
0.32
16
69
66
476
1.42
1.89
1.1
1.0
—
—
—
0
0
12
52
2.32
1.88
1.2
1.1
1.07
1.05
ratio
—
7
22
9
34
2.66
1.86
1.4
2.0
—
—
—
0
0
9
34
2.66
1.86
1.4
2.0
—
—
—
0
0
6
17
3.54
1.84
1.0
1.2
—
—
—
0
0
903
8814
1.43
1.83
38.7
18.3
260.62
254.41
e9/l
1.82
886
8599
19
101
1.90
1.81
1.4
1.4
7.16
7.39
mmol/l
0.11
19
85
15
73
2.07
1.81
1.1
2.1
23.80
22.04
nmol/l
0.19
15
68
18
94
1.93
1.81
1.6
1.5
—
—
—
0
0
18
94
1.93
1.81
1.6
1.5
—
—
—
0
0
8
29
2.77
1.79
1.4
1.3
—
—
—
0
0
34
216
1.60
1.78
1.2
1.2
—
—
—
0
0
73
544
1.37
1.75
3.3
2.6
61.93
70.53
ml/min/173m2
0.90
45
216
903
8822
1.42
1.73
38.6
18.3
4.41
4.51
e12/l
7.03
885
8584
22
125
1.78
1.73
1.0
1.2
68.20
112.05
iu/ml
—
5
30
903
8826
1.41
1.68
39.0
18.4
131.03
135.21
g/l
13.83
892
8706
902
8815
1.40
1.68
38.4
18.3
39.37
40.12
%
4.22
871
8305
93
725
1.31
1.66
2.1
1.7
—
—
—
0
0
217
1869
1.21
1.65
1.9
1.6
—
—
—
0
0
116
933
1.28
1.64
2.4
1.8
—
—
—
0
0
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
38
256
1.50
1.57
3.4
6.4
1.54
1.61
%
0.18
33
239
24
145
1.67
1.55
1.3
1.2
1.13
5.70
u/ml
—
8
50
18
309
0.57
1.55
1.6
1.5
—
—
—
0
0
25
153
1.65
1.54
1.4
1.3
—
—
—
0
0
14
71
1.99
1.54
1.1
1.0
—
—
—
0
0
5
15
3.34
1.52
2.4
1.3
—
—
—
0
0
25
155
1.63
1.48
4.4
3.8
43.21
22.47
mg/l
1.01
19
96
10
45
2.24
1.46
1.7
2.2
—
—
—
0
0
14
73
1.93
1.44
4.4
1.6
—
—
—
0
0
7
29
2.42
1.39
1.7
1.3
—
—
—
0
0
7
29
2.42
1.39
2.0
2.9
235.29
198.38
u/l
—
7
29
7
29
2.42
1.39
1.7
1.3
—
—
—
0
0
12
61
1.98
1.33
1.2
1.1
—
—
—
0
0
86
1066
0.79
1.32
2.8
2.9
0.83
0.73
ug/l
0.49
58
676
150
1275
1.21
1.32
3.5
3.5
137.62
374.48
ng/l
1.32
90
920
8
34
2.36
1.29
1.6
1.3
—
—
—
0
0
8
35
2.30
1.27
1.6
1.3
—
—
—
0
0
9
44
2.06
1.27
1.1
1.6
1.78
1.92
u/field
—
9
33
28
408
0.68
1.24
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
45
2.01
1.23
1.6
1.2
—
—
—
0
0
32
221
1.46
1.22
1.7
1.7
36.44
39.33
nmol/l
0.42
32
214
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
26
172
1.53
1.21
1.4
1.2
—
—
—
0
0
10
50
2.01
1.16
1.0
1.1
295.70
292.64
mg/l
—
10
45
32
224
1.44
1.15
2.6
1.8
3.08
5.22
iu/l
1.46
20
81
15
87
1.74
1.15
1.2
1.1
—
—
—
0
0
5
20
2.51
1.15
4.2
3.5
—
—
—
0
0
5
20
2.51
1.15
4.2
3.5
—
—
—
0
0
8
40
2.01
1.12
2.5
3.0
—
—
—
0
0
194
1715
1.16
1.10
5.9
3.8
1.02
1.02
kg/l
0.20
28
251
24
161
1.50
1.07
3.4
2.2
170.32
134.03
ug/min
0.12
17
101
42
314
1.35
1.06
1.4
1.5
—
—
—
0
0
17
105
1.63
1.06
2.4
2.2
—
—
—
0
0
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
63
503
1.27
1.01
2.3
2.2
11.95
12.43
nmol/l
0.19
56
449
24
343
0.69
0.99
1.9
2.0
—
—
—
0
0
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
10
55
1.83
0.92
1.2
2.9
—
—
—
0
0
20
134
1.50
0.92
1.1
1.1
—
—
—
0
0
15
94
1.61
0.91
1.5
1.4
—
—
—
0
0
11
63
1.75
0.90
1.2
1.2
1.35
1.45
nmol/l
0.11
11
56
6
29
2.08
0.89
1.2
1.3
—
—
—
0
0
101
867
1.18
0.85
4.1
4.1
33.67
31.63
%
0.83
75
607
15
96
1.57
0.84
1.5
1.4
—
—
—
0
0
15
96
1.57
0.84
1.5
1.4
—
—
—
0
0
60
492
1.23
0.81
1.4
1.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
10
59
1.70
0.76
1.2
1.6
0.96
1.10
promille
—
5
44
5
25
2.01
0.72
2.0
2.7
13.98
15.57
umol/l
—
5
25
10
60
1.67
0.72
1.1
1.3
—
—
—
0
0
20
143
1.41
0.70
1.1
1.1
—
11.24
—
0
10
27
350
0.76
0.66
2.2
1.7
—
—
—
0
0
13
86
1.52
0.66
1.1
1.0
—
—
—
0
0
14
95
1.48
0.64
1.6
1.4
—
—
—
0
0
14
95
1.48
0.64
1.6
1.4
—
—
—
0
0
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
14
96
1.47
0.61
1.6
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
330.42
—
0
12
10
64
1.57
0.58
2.0
1.7
10.62
11.52
umol/l
—
10
58
198
1837
1.10
0.55
3.8
4.8
1.79
2.39
ug/l
1.20
167
1641
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
26
207
1.26
0.50
1.6
1.6
—
—
—
0
0
10
68
1.48
0.47
2.9
1.3
—
—
—
0
0
25
202
1.24
0.44
1.2
1.1
1.19
3.23
u/ml
0.92
13
106
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
0.31
0.29
g/l
—
5
25
9
70
1.29
0.36
1.3
1.1
—
—
—
0
0
740
7508
0.94
0.35
4.5
3.9
4.47
4.66
mmol/l
5.72
681
7033
11
82
1.35
0.34
2.6
2.7
104.91
105.35
mmol/l
0.11
11
82
11
82
1.35
0.34
2.6
2.7
3.99
4.05
mmol/l
0.34
11
82
22
183
1.21
0.32
1.2
1.1
3.54
8.33
u/ml
1.82
11
100
738
7473
0.95
0.29
4.4
3.9
1.41
1.47
mmol/l
3.42
677
6965
21
177
1.19
0.27
1.1
1.1
2.77
1.71
u/ml
—
10
90
14
115
1.22
0.23
1.6
1.6
6.55
7.74
mmol/l
1.78
14
109
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
58
537
1.09
0.21
4.7
2.5
6.83
6.25
ug/l
0.09
51
477
711
7185
0.96
0.21
4.0
3.6
1.30
1.25
mmol/l
0.85
647
6659
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
6
53
1.13
0.18
1.3
1.3
74.67
74.89
umol/l
—
6
53
20
220
0.91
0.12
1.3
1.1
—
—
—
0
0
31
329
0.94
0.09
1.5
1.4
—
—
—
0
0
82
845
0.97
0.08
7.2
6.3
—
—
—
0
0
8
78
1.03
0.07
1.9
2.1
—
22.74
—
0
22
14
131
1.07
0.03
1.0
1.0
1.57
1.75
u/ml
—
6
58
17
162
1.05
0.02
1.8
1.9
—
—
—
0
0
761
7621
0.99
0.01
4.7
4.3
2.64
2.77
mmol/l
4.00
695
7091
22
213
1.03
0.01
1.2
1.3
2.07
3.03
ug/l
1.36
22
195
11
104
1.06
0.01
1.3
1.5
—
—
—
0
0
7
79
0.89
-0.00
6.3
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
59
0.85
-0.00
2.6
1.5
0.77
0.98
g/l
—
5
59
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
2.10
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_CARRIER_INFECTIOUS_DISEA – Carrier of infectious disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).